Pacer Advisors Inc. Buys 146,968 Shares of Proto Labs, Inc. (NYSE:PRLB)

Pacer Advisors Inc. boosted its stake in shares of Proto Labs, Inc. (NYSE:PRLB) by 9,033.1% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 148,595 shares of the industrial products company’s stock after acquiring an additional 146,968 shares during the period. Pacer Advisors Inc.’s holdings in Proto Labs were worth $5,207,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Sterling Capital Management LLC increased its stake in shares of Proto Labs by 764.1% in the 4th quarter. Sterling Capital Management LLC now owns 795 shares of the industrial products company’s stock valued at $31,000 after purchasing an additional 703 shares during the last quarter. GAMMA Investing LLC increased its stake in shares of Proto Labs by 249.4% in the 1st quarter. GAMMA Investing LLC now owns 926 shares of the industrial products company’s stock valued at $32,000 after purchasing an additional 661 shares during the last quarter. Quarry LP increased its stake in shares of Proto Labs by 175.7% in the 4th quarter. Quarry LP now owns 1,585 shares of the industrial products company’s stock valued at $62,000 after purchasing an additional 1,010 shares during the last quarter. CWM LLC increased its stake in shares of Proto Labs by 50.4% in the 1st quarter. CWM LLC now owns 1,840 shares of the industrial products company’s stock valued at $64,000 after purchasing an additional 617 shares during the last quarter. Finally, KLP Kapitalforvaltning AS bought a new position in shares of Proto Labs in the 4th quarter valued at $192,000. Institutional investors own 84.54% of the company’s stock.

Proto Labs Stock Performance

Shares of PRLB opened at $39.67 on Tuesday. Proto Labs, Inc. has a 52-week low of $25.75 and a 52-week high of $46.73. The firm has a market cap of $942.96 million, a price-to-earnings ratio of 66.12 and a beta of 1.33. The business’s fifty day moving average is $39.07 and its 200-day moving average is $38.49.

Proto Labs (NYSE:PRLB) last posted its earnings results on Friday, May 2nd. The industrial products company reported $0.33 EPS for the quarter, beating the consensus estimate of $0.29 by $0.04. The firm had revenue of $126.21 million during the quarter, compared to the consensus estimate of $123.71 million. Proto Labs had a return on equity of 2.22% and a net margin of 2.99%. The business’s quarterly revenue was down 1.3% on a year-over-year basis. During the same period last year, the company earned $0.40 earnings per share. As a group, research analysts forecast that Proto Labs, Inc. will post 0.81 EPS for the current fiscal year.

Analysts Set New Price Targets

Separately, Wall Street Zen upgraded Proto Labs from a “buy” rating to a “strong-buy” rating in a research note on Tuesday, May 6th.

About Proto Labs

Proto Labs, Inc, together with its subsidiaries, operates as a digital manufacturer of custom parts in the United States and Europe. The company offers injection molding; computer numerical control machining; three-dimensional printing; and sheet metal fabrication products. It serves developers and engineers, who use 3D computer-aided design software to design products across a range of end-markets.